Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Immupharma Share Price
  4. Immupharma Share Regulatory News
  5. AGM Result

Pin to quick picksImmupharma Regulatory News (IMM)

Immupharma Information

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes
Get Live Data
4.46    -0.2225 (-4.65%)
Bid:
4.40
Ask:
4.725
Spread: 0.325 (7.386%)
Market Cap: £27.83m
IMM Live PriceLast checked at - London Stock Exchange

Intraday Immupharma Share Chart

AGM Result

5 Aug 2008 15:44

RNS Number : 7058A
Immupharma PLC
05 August 2008
Β 

ο»Ώ

For Immediate Release

5 August 2008

Β Β 

AGM StatementΒ 

ImmuPharma plc (LSE:IMM), the specialist pharmaceutical discovery andΒ development company, held its AGM earlier today and is pleased toΒ announce that all resolutions were passed.

For further information please contact:Β 

ImmuPharma PLCΒ 

Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080 Richard Warr, Chairman +44 20 7152 4080 Dr Robert Zimmer, President & Chief +33 389 32 76 50 Scientific OfficerΒ 

Buchanan Communications +44 20 7466 5000

Lisa Baderoon Rebecca SkyeΒ DietrichΒ 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RAGILFSSTLIEIIT
12345678910
Date   Source Headline
5th Jun 20247:00 amRNSFinal Results
3rd Jun 202410:09 amRNSRealisation-c£1.5m on sale of shares in Incanthera
3rd May 20247:00 amRNSHolding(s) in Company
24th Apr 20247:12 amRNSIMMUPHARMA AT BIO-EQUITY 2024 12-14 May
19th Apr 20247:00 amRNSGrant of Share Options
2nd Apr 20247:03 amRNSNew intellectual property strategy initiated
25th Mar 20247:25 amRNSIncanthera provides Comm'l Update/Revenue F'casts
19th Mar 20247:00 amRNSGrant of Share Options
14th Mar 20247:00 amRNSIMMUPHARMA AT BIO-EUROPE SPRING 2024
6th Mar 20247:00 amRNSFinancial, Business and Portfolio Develop't Update
28th Dec 20231:35 pmRNSHolding(s) in Company
19th Dec 20232:50 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSSimbec-Orion appointed as CRO
18th Dec 20237:15 amRNSIncanthera - Comm'l Skincare Deal/£1M Fundraise
13th Sep 20233:47 pmRNSHolding(s) in Company
7th Sep 20237:00 amRNSResult of Retail Offer and Director Shareholding
31st Aug 20237:02 amRNSWRAP Retail Offer for up to £0.5m
31st Aug 20237:01 amRNSSubscription to raise £1.35m; Sharing Agr, RPT
31st Aug 20237:00 amRNSInterim results
21st Aug 20237:00 amRNSExtension of warrants in Incanthera plc
11th Aug 202312:04 pmRNSDirectorate Change
30th Jun 20231:12 pmRNSResult of AGM
19th Jun 20237:00 amRNSLupuzor Update
6th Jun 20237:00 amRNSIMM RNS Posting of RA and Notice of AGM 30 June 23
18th May 20237:00 amRNSPositive Pre-IND meeting with FDA
11th May 20237:00 amRNSFinal Results
10th May 20231:56 pmRNSHolding(s) in Company
19th Apr 20237:00 amRNSLupozor Update - FDA confirms Type-C meeting date
12th Apr 20237:00 amRNSCIDP P140 Clinical Program Update
27th Mar 20237:00 amRNSLupuzor™ Update
9th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20237:00 amRNSCollaboration with Orano on ImmuPharma Peptide
6th Feb 20237:00 amRNSLupuzor™ Update
27th Jan 20234:25 pmRNSTR-1: Notification of major holdings
4th Jan 20235:26 pmRNSTR-1: Notification of major holdings
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:58 pmRNSTR-1: Notification of major holdings
22nd Dec 20227:55 amRNSGrant of Options
22nd Dec 20227:00 amRNSEnd of Year Update
22nd Nov 20223:15 pmRNSHolding(s) in Company
14th Nov 20224:40 pmRNSSecond Price Monitoring Extn
14th Nov 20224:35 pmRNSPrice Monitoring Extension
11th Nov 20227:31 amRNSLupuzor Update
11th Oct 20224:40 pmRNSSecond Price Monitoring Extn
11th Oct 20224:35 pmRNSPrice Monitoring Extension
7th Oct 20224:44 pmRNSCompany Secretary Change
6th Oct 20225:17 pmRNSHolding(s) in Company
30th Sep 20227:30 amRNSLupuzor Update
30th Sep 20227:00 amRNSInterim Results or the 6mths Ended 30 June 2022
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
HLMA
Halma
LSE
-15.38%
BGS
Baillie Gifford Shin Nippon PLC
LSE
0.52%
POW
Power Metal Resources PLC
LSE
-5.17%
VSL
Vpc Specialty
LSE
0.00%
FUTR
Future
LSE
-2.66%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
-15.79%
PREM
Premier African Minerals
LSE
0.00%
GST
GSTechnologies
LSE
6.00%
PPP
Pennpetro Energy
LSE
0.00%
KEFI
Kefi Gold & Copper
LSE
0.00%